199.88 +0.61 (0.31%)
After hours: 7:44PM EDT
|Bid||199.46 x 1000|
|Ask||199.91 x 1000|
|Day's Range||199.15 - 205.25|
|52 Week Range||169.04 - 221.93|
|Beta (3Y Monthly)||0.33|
|PE Ratio (TTM)||26.17|
|Earnings Date||Oct 22, 2019|
|Forward Dividend & Yield||5.00 (2.42%)|
|1y Target Est||232.44|
Lyft is climbing after the co-founders told the 'Wall Street Journal' that the company is "going to be profitable on an adjusted EBITDA basis a year before analysts expect us to." Yahoo Finance's Zack Guzman, Heidi Chung, and Independent Women's Forum Board Member and former NY Congresswoman, Nan Hayworth, discuss.
Mcdonalds reported a miss on profit and sales in its third quarter earnings, and investors are disappointed. Yahoo Finance’s Brian Sozzi, Alexis Christoforous, and Heidi Chung break down the numbers.
U.S. stock index futures pointed to a flat open Tuesday as investors looked at a series of key earnings form McDonald's and United Technologies. Also, Bitcoin and gold are both seeing a rebound.
Shares of McDonald's dropped on Tuesday after the company reported a quarterly profit that missed Wall Street expectations. It's the burger chain's first miss in two years. And it comes as McDonald's invests aggressively in revamping its 14,000 restaurants in the U.S. to include digital ordering kiosks, mobile ordering and Pay and Pick-up services. And sales did rise - 4.8% in the third quarter. But that fell below the nearly 5.2% growth analysts expected, according to IBES data from Refinitiv. This comes as competition in the restaurant space is intensifying. With rival fast-food chains challenging McDonald's dominance with value meals and plant-based food options. Burger King and KFC for example jumped on the plant-based burger trend faster than McDonald's, which is currently testing a burger using Beyond Meat patties in Canada.
It was a mixed bag for the four members of the Dow Jones Industrial Average that reported third-quarter earnings on Tuesday, as disappointing numbers from McDonald’s Corp. and Travelers Cos. weighed against beats from United Technologies Co. and Procter & Gamble.
Biogen stock was a big winner Tuesday on news it plans to file for U.S. regulatory approval for its Alzheimer's treatment aducanumab.
Earlier on Tuesday, the S&P 500 and the Dow Jones Industrial Average had risen modestly as upbeat forecasts from Procter & Gamble Co and United Technologies Corp offset lower-than-expected results from McDonald's Corp and Travelers Cos Inc. With Tuesday's losses the S&P 500 fell below 3000, but remained within 1% of its record closing high in July. The Dow Jones Industrial Average fell 39.54 points, or 0.15%, to 26,788.1, the S&P 500 lost 10.73 points, or 0.36%, to 2,995.99 and the Nasdaq Composite dropped 58.69 points, or 0.72%, to 8,104.30.
McDonald's missed third-quarter earnings and revenue views as U.S. same-store sales also fell short. Shares plunged.
U.S. stock indexes skidded lower into Tuesday's close, amid negative headlines on Brexit and reports related to President Donald Trump's impeachment inquiry. The Dow Jones Industrial Average closed nearly 40 points, or 0.2%, lower at 26,788, with a post-earnings skid for shares of Travelers Cos. Inc. , off $11.76, or 8.3%, and McDonald's Corp. , down $10.58, or 5%, combining to deliver a 151-put headwind to the blue-chip index. Meanwhile, the S&P 500 index closed down 0.4% at 2,996, slipping below a psychologically significant level at 3,000, while the Nasdaq Composite Index finished 0.7% lower at 8,104. All closing levels are on a preliminary basis. The Wall Street Journal and others reported that U.S. diplomat Kurt Volker told the Ukrainian president he needed to convince Trump he was willing to investigate corruption and alleged Ukrainian 2016 election interference against former Vice President Joe Biden and his son, said the paper, citing people familiar with the former envoy's recent testimony to Congress. The disclosures may intensify the Congressional investigation into allegations that Trump withheld federal funds in exchange for a probe into a political rival. Separately, investors focused on on Brexit after U.K. lawmakers endorsed Prime Minister Boris Johnson's plan to leave the EU but voted against a fast-track plan that would have seen the country leave the trade bloc by Oct. 31, increasing some uncertainty around Brexit.
The top story: Biogen (NASDAQ: BIIB) pulled a fast one on investors who threw in the towel on the company based on the March news that it had discontinued trials for its Alzheimer's drug aducanumab. Before the open, Biogen announced a third-quarter EPS and sales beat — and its plans for a regulatory filing for aducanumab following new analysis. Since the issue has had several whipsaws off the news regarding this drug, the PreMarket Prep co-hosts viewed the spike as a selling opportunity for a few different reasons.
The stock market rally petered out in afternoon trading on Tuesday. Chipotle stock hits a key buy point ahead of earnings.
DOW UPDATE Shares of Travelers and McDonald's are posting losses Tuesday afternoon, though the Dow Jones Industrial Average is trading essentially flat. The Dow (DJIA) was most recently trading 2 points, or 0.
The Dow Jones Industrial Average led Tuesday, as big gains by blue chips including Boeing and Disney offset big losses from McDonald's and Travelers.
Third quarter earnings reports are starting to pile up. Here's a quick read on the health of the U.S. consumer amid talk of a recession in early 2020.
Despite big losses in the stock market today by the likes of McDonald's and Travelers, the Dow Jones Industrial Average is holding up pretty well.
Early Tuesday, the burger giant said it earned $2.11 a share, a dime below the $2.21 consensus estimate, on revenue of $5.43 billion, which was also slightly below the $5.47 billion analysts were expecting.